PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
42.50
+2.02 (4.99%)
Oct 29, 2024, 4:00 PM EDT - Market closed

PTC Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
900.45937.82698.8538.59380.77306.98
Upgrade
Revenue Growth (YoY)
9.98%34.20%29.75%41.45%24.04%15.96%
Upgrade
Cost of Revenue
602.74732.05696.17573.01442.99269.59
Upgrade
Gross Profit
297.71205.772.63-34.42-62.2237.39
Upgrade
Selling, General & Admin
299.95332.54326285.77244.46202.54
Upgrade
Operating Expenses
490.17555.18442.55340.52281.36230.19
Upgrade
Operating Income
-192.45-349.4-439.93-374.94-343.58-192.8
Upgrade
Interest Expense
-156.76-128.88-94.87-86.02-56.35-12.49
Upgrade
Other Non Operating Income (Expenses)
12.0411.81-31.92-45.1951.6311.53
Upgrade
EBT Excluding Unusual Items
-346.27-466.48-566.71-506.15-348.3-193.76
Upgrade
Merger & Restructuring Charges
-----0.3-
Upgrade
Gain (Loss) on Sale of Investments
-4.68-1.98-13.29-12.6933.562.19
Upgrade
Asset Writedown
-0.16-217.8-33.38--54-
Upgrade
Other Unusual Items
-139.16-9.8625.90.5-33.89-48.36
Upgrade
Pretax Income
-494.07-696.11-587.49-518.34-402.93-239.93
Upgrade
Income Tax Expense
-14.55-69.51-28.475.5635.2311.65
Upgrade
Net Income
-479.52-626.6-559.02-523.9-438.16-251.58
Upgrade
Net Income to Common
-479.52-626.6-559.02-523.9-438.16-251.58
Upgrade
Shares Outstanding (Basic)
767572706659
Upgrade
Shares Outstanding (Diluted)
767572706659
Upgrade
Shares Change (YoY)
3.87%4.34%1.79%6.72%12.17%26.38%
Upgrade
EPS (Basic)
-6.31-8.37-7.79-7.43-6.64-4.27
Upgrade
EPS (Diluted)
-6.31-8.37-7.79-7.43-6.64-4.27
Upgrade
Free Cash Flow
-129.64-186.86-388.67-279.55-211.91-112.4
Upgrade
Free Cash Flow Per Share
-1.71-2.50-5.42-3.97-3.21-1.91
Upgrade
Gross Margin
33.06%21.94%0.38%-6.39%-16.34%12.18%
Upgrade
Operating Margin
-21.37%-37.26%-62.95%-69.62%-90.23%-62.80%
Upgrade
Profit Margin
-53.25%-66.81%-80.00%-97.27%-115.07%-81.95%
Upgrade
Free Cash Flow Margin
-14.40%-19.92%-55.62%-51.90%-55.65%-36.61%
Upgrade
EBITDA
12.72-112.81-311.09-310.81-300.09-160.62
Upgrade
EBITDA Margin
1.41%-12.03%-44.52%-57.71%-78.81%-52.32%
Upgrade
D&A For EBITDA
205.17236.59128.8464.1343.4932.18
Upgrade
EBIT
-192.45-349.4-439.93-374.94-343.58-192.8
Upgrade
EBIT Margin
-21.37%-37.26%-62.95%-69.62%-90.23%-62.80%
Upgrade
Revenue as Reported
900.45937.82698.8538.59380.77306.98
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.